Get Integrated Data for Your Specialty and Interest Aresa
 
Category Select :
Items 141 ~ 160 of 26020, Page 8 of 1301
141. Malaria vaccine pilot launched in Malawi - 04/23/2019
 WHO
  Country first of three in Africa to roll out landmark vaccine / An innovation milestone, three decades in development / A model public-private partnership
142. Obesity Linked with Differences in Form and Structure of the Brain - 04/23/2019
 Radiological Society of North America
  MRI shows that higher levels of body fat are associated with differences in the brain's form and structure. / Brain imaging results from more than 12,000 participants in the UK Biobank study were analyzed. / Researchers found that higher total body fat percentage increased the likelihood of changes to the brain's white matter. In men, gray matter volume was also reduced.
143. Statement from Jeffrey Shuren, M.D., J.D., Director of the FDAs Center for Devices and Radiological Health, on new steps to help reduce risks associated with surgical staplers for internal use and implantable staples - 04/23/2019
 U.S. FOOD & DRUG ADMINISTRATION
144. The Link Between Weight and Cancer Risk - 04/23/2019
 American Cancer Society
  Being overweight or obese puts you at greater risk for some types of cancer. Learn about the connection between weight and cancer ? and what you can do about it.
145. Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agencys new steps to strengthen the process of initiating voluntary recalls - 04/23/2019
 U.S. FOOD & DRUG ADMINISTRATION
146. Statement from Peter Marks, M.D., Ph.D., director of FDAs Center for Biologics Evaluation and Research, on FDAs continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccine - 04/22/2019
 U.S. FOOD & DRUG ADMINISTRATION
147. FDA Approves Mercks KEYTRUDA (pembrolizumab) in Combination With Inlyta (axitinib) as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma (RCC) - 04/22/2019
 MERCK
  Approval Based on Results of KEYNOTE-426, Where KEYTRUDA in Combination With Axitinib Reduced the Risk of Death by Nearly Half Compared to Sunitinib
148. FDA permits marketing of first medical device for treatment of ADHD - 04/19/2019
 U.S. FOOD & DRUG ADMINISTRATION
149. FDA approves first generic naloxone nasal spray to treat opioid overdose - 04/19/2019
 U.S. FOOD & DRUG ADMINISTRATION
  Agency is also taking new steps to support development of over-the-counter and additional generics of naloxone to help reduce opioid overdose deaths, increase access to emergency treatment
150. WHO releases first guideline on digital health interventions - 04/17/2019
 WHO
  Digital health interventions are not sufficient on their own /
151. Medtronic VenaSeal(TM) Closure System Demonstrates Durable and Consistent Outcomes at Five Years in Patients with Chronic Venous Disease - 04/17/2019
 Medtronic
  Medtronic plc (NYSE:MDT) today announced five-year outcomes from the VeClose Extension Study. Nick Morrison, M.D., Center for Vein Restoration, Mesa, Ariz., presented at the 2019 Charing Cross Symposium in London. The new data demonstrate durable and consistent long-term outcomes of the Medtronic VenaSeal(TM) Closure System in treating patients with chronic venous disease.
152. Medtronic Data Expands on Key Aortic Solutions for Challenging Anatomies - 04/17/2019
 Medtronic
  New EndoSuture Aneurysm Repair (ESAR) and Valiant Navion(TM) Data Presented at Charing Cross Demonstrate Safety and Efficacy in Patients with Complex Anatomies
153. Abbott Reports First-Quarter 2019 Results - 04/17/2019
 Abbott
  ABBOTT PARK, Ill., April 17, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2019.
154. FDA takes action to protect womens health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to remove all devices from the market - 04/16/2019
 U.S. FOOD & DRUG ADMINISTRATION
155. Radiology Publishes Roadmap for AI in Medical Imaging - 04/16/2019
 Radiological Society of North America
  In August 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Md., to explore the future of artificial intelligence (AI) in medical imaging. The workshop was co-sponsored by NIH, the Radiological Society of North America (RSNA), the American College of Radiology (ACR) and The Academy for Radiology and Biomedical Imaging Research (The Academy). The organizers aimed to foster collaboration in applications for diagnostic medical imaging, identify knowledge gaps and develop a roadmap to prioritize research needs. The group''s research roadmap was published today as a special report in the journal Radiology.
156. FDA Approves First Targeted Therapy for Bladder Cancer - 04/16/2019
 American Cancer Society
  The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.
157. FDA Statement from Deputy Commissioner for Food Policy and Response Frank Yiannas on new steps to protect consumers from unlawful ingredients in dietary supplements - 04/16/2019
 U.S. FOOD & DRUG ADMINISTRATION
158. FDA Warns of Cancer Risk in a Type of Uterine Fibroid Surgery - 04/15/2019
 American Cancer Society
  The US Food and Drug Administration (FDA) is warning women and doctors about the risks of a certain technique used in surgery for uterine fibroids.
159. At WHO Forum on Medicines, countries and civil society push for greater transparency and fairer prices - 04/13/2019
 WHO
  WHO to continue to facilitate countries' information-sharing to improve transparency on prices
160. Results of Phase 3 Trial Evaluating Mercks ZERBAXA (ceftolozane and tazobactam) versus Meropenem for Treatment of Adult Patients with Ventilated Nosocomial Pneumonia (VNP) to be Presented at ECCMID 2019 - 04/13/2019
 MERCK
  ASPECT-NP Clinical Trial Results Demonstrated Non-Inferiority of ZERBAXA to Meropenem for Treating Ventilated Nosocomial Pneumonia in Primary and Key Secondary Endpoints
<<  <  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8[9]  [10]  >  >>
 


Copyright ~2018 by Medisurf. All Rights Reserved Terms of Service Privacy Email : medalls@medalls.com